325 related articles for article (PubMed ID: 32631361)
21. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.
Tan CS; Koralnik IJ
Lancet Neurol; 2010 Apr; 9(4):425-37. PubMed ID: 20298966
[TBL] [Abstract][Full Text] [Related]
22. [New trends in progressive multifocal leukoencephalopathy].
Gasnault J; Taoufik Y
Rev Neurol (Paris); 2006 Jan; 162(1):43-56. PubMed ID: 16446622
[TBL] [Abstract][Full Text] [Related]
23. Progressive multifocal leukoencephalopathy: new concepts.
Lima MA
Arq Neuropsiquiatr; 2013 Sep; 71(9B):699-702. PubMed ID: 24141508
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibodies and progressive multifocal leukoencephalopathy.
Berger JR; Houff SA; Major EO
MAbs; 2009; 1(6):583-9. PubMed ID: 20073129
[TBL] [Abstract][Full Text] [Related]
25. Progressive multifocal leukoencephalopathy.
Berger JR
Curr Neurol Neurosci Rep; 2007 Nov; 7(6):461-9. PubMed ID: 17999891
[TBL] [Abstract][Full Text] [Related]
26. Treating progressive multifocal leukoencephalopathy with interleukin 7 and vaccination with JC virus capsid protein VP1.
Sospedra M; Schippling S; Yousef S; Jelcic I; Bofill-Mas S; Planas R; Stellmann JP; Demina V; Cinque P; Garcea R; Croughs T; Girones R; Martin R
Clin Infect Dis; 2014 Dec; 59(11):1588-92. PubMed ID: 25214510
[TBL] [Abstract][Full Text] [Related]
27. Human polyomavirus JC latency and reactivation status in blood of HIV-1-positive immunocompromised patients with and without progressive multifocal leukoencephalopathy.
Andréoletti L; Dubois V; Lescieux A; Dewilde A; Bocket L; Fleury HJ; Wattré P
AIDS; 1999 Aug; 13(12):1469-75. PubMed ID: 10465069
[TBL] [Abstract][Full Text] [Related]
28. New insights into progressive multifocal leukoencephalopathy.
Koralnik IJ
Curr Opin Neurol; 2004 Jun; 17(3):365-70. PubMed ID: 15167073
[TBL] [Abstract][Full Text] [Related]
29. Synthetic antibodies and peptides recognizing progressive multifocal leukoencephalopathy-specific point mutations in polyomavirus JC capsid viral protein 1.
Chen G; Gorelik L; Simon KJ; Pavlenco A; Cheung A; Brickelmaier M; Chen LL; Jin P; Weinreb PH; Sidhu SS
MAbs; 2015; 7(4):681-92. PubMed ID: 25879139
[TBL] [Abstract][Full Text] [Related]
30. Progressive multifocal leukoencephalopathy in patients with chronic kidney disease.
Meylor J; Artunduaga DC; Mendoza M; Hooshmand SI; Obeidat AZ
Neurol Sci; 2024 Apr; 45(4):1619-1624. PubMed ID: 37950135
[TBL] [Abstract][Full Text] [Related]
31. Advances in the management of PML: focus on natalizumab.
Fox R
Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S33-7. PubMed ID: 22123933
[TBL] [Abstract][Full Text] [Related]
32. Revisiting JC virus and progressive multifocal leukoencephalopathy.
Rocchi A; Sariyer IK; Berger JR
J Neurovirol; 2023 Oct; 29(5):524-537. PubMed ID: 37659983
[TBL] [Abstract][Full Text] [Related]
33. Progressive multifocal leukoencephalopathy after natalizumab monotherapy.
Lindå H; von Heijne A; Major EO; Ryschkewitsch C; Berg J; Olsson T; Martin C
N Engl J Med; 2009 Sep; 361(11):1081-7. PubMed ID: 19741229
[TBL] [Abstract][Full Text] [Related]
34. Evidence for involvement of transforming growth factor beta1 signaling pathway in activation of JC virus in human immunodeficiency virus 1-associated progressive multifocal leukoencephalopathy.
Enam S; Sweet TM; Amini S; Khalili K; Del Valle L
Arch Pathol Lab Med; 2004 Mar; 128(3):282-91. PubMed ID: 14987161
[TBL] [Abstract][Full Text] [Related]
35. JC papovavirus large tumor (T)-antigen expression in brain tissue of acquired immune deficiency syndrome (AIDS) and non-AIDS patients with progressive multifocal leukoencephalopathy.
Stoner GL; Ryschkewitsch CF; Walker DL; Webster HD
Proc Natl Acad Sci U S A; 1986 Apr; 83(7):2271-5. PubMed ID: 3008157
[TBL] [Abstract][Full Text] [Related]
36. [Neurological complications of JC virus infection: A review].
Moulignier A; Lecler A
Rev Med Interne; 2021 Mar; 42(3):177-185. PubMed ID: 33168355
[TBL] [Abstract][Full Text] [Related]
37. JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy.
Koralnik IJ; Du Pasquier RA; Letvin NL
J Virol; 2001 Apr; 75(7):3483-7. PubMed ID: 11238876
[TBL] [Abstract][Full Text] [Related]
38. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy.
Beck ES; Cortese I
Curr Opin Virol; 2020 Feb; 40():19-27. PubMed ID: 32279025
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.
White MK; Sariyer IK; Gordon J; Delbue S; Pietropaolo V; Berger JR; Khalili K
Rev Med Virol; 2016 Mar; 26(2):102-14. PubMed ID: 26663440
[TBL] [Abstract][Full Text] [Related]
40. Update on progressive multifocal leukoencephalopathy.
Steiner I; Berger JR
Curr Neurol Neurosci Rep; 2012 Dec; 12(6):680-6. PubMed ID: 22991070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
